XENTRIA

What this means for you

Approved and waiting on proof of use. It will register unless the applicant drops it, and its 17 Jan 2025 filing date already counts against anyone who files later.

Record

Serial number

99007883

Mark type

Word mark

Filed

17 Jan 2025

Published for opposition

10 Nov 2026

Attorney of record

Eric R. Moran

Goods and services

• Class 005 — Pharmaceuticals: Biologic, biosimilar, and pharmaceutical preparations for the treatment of bone disease; Biologic, biosimilar, and pharmaceutical preparations for use in the treatment of oncological and metabolic diseases and disorders, and complications associated therewith; Biologic, biosimilar, and pharmaceutical preparations for the treatment of diabetes; Biologic, biosimilar, and pharmaceutical preparations for treatment and prevention of autoimmune diseases and autoimmune disorders; Biologic, biosimilar, and pharmaceutical oncology preparations for the treatment of cancer; Anti-inflammatories; Biologic, biosimilar, and pharmaceutical preparations for the treatment and prevention of immune system related diseases and disorders; Biologic, biosimilar, and pharmaceutical preparations for use in dermatology; Biologic, biosimilar, and pharmaceutical preparations for use in rheumatology; Biologic, biosimilar, and pharmaceutical preparations, namely, anti-tumor necrosis factor alpha (TNF-a) receptor monoclonal antibody for the treatment and prevention of disease influenced by TNF-a production; Biologic, biosimilar, and pharmaceutical preparations, namely, biopharmaceuticals based on human monoclonal antibodies for the treatment and prevention of immune and inflammatory diseases and disorders

Owner

• Xentria, Inc., Chicago, IL, US

Prosecution history

• 14 Oct 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
• 14 Oct 2026 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
• 14 Oct 2026 — EXAMINER'S AMENDMENT ENTERED
• 14 Oct 2026 — EXAMINERS AMENDMENT E-MAILED
• 14 Oct 2026 — EXAMINERS AMENDMENT -WRITTEN
• 03 Sept 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
• 03 Sept 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
• 03 Sept 2026 — TEAS REQUEST FOR RECONSIDERATION RECEIVED
• 01 Jun 2026 — APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
• 01 Jun 2026 — APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
• 03 Mar 2026 — NOTIFICATION OF FINAL REFUSAL EMAILED
• 03 Mar 2026 — FINAL REFUSAL E-MAILED
• 03 Mar 2026 — FINAL REFUSAL WRITTEN
• 03 Feb 2026 — PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
• 07 Jan 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED